Table 6

KEGG pathways containing target proteins or their interacting partners

Pathway Name

Corrected p-value

Number of target proteins selected

Total number of proteins in pathway

Fraction of population as targets

MAP kinase signaling pathway

4.26E-05

19

259

0.073

Antigen processing and presentation

6.66E-05

10

80

0.125

Alzheimer's disease

1.11E-04

6

28

0.214

Long-term potentiation

5.78E-04

8

65

0.123

Neurodegenerative disorders

0.0011

6

39

0.154

Long-term depression

0.0018

8

75

0.107

Arginine and proline metabolism

0.0018

7

34

0.201

Adipocytokine signaling pathway

0.0054

7

73

0.096


Fang et al. BMC Chemical Biology 2009 9:5   doi:10.1186/1472-6769-9-5

Open Data